Posted by Richard Willet Posted on 26 May 2020

Trump Unveils Plan That Would See Big Pharma Reap Massive Profits from COVID-19 Vaccine

A former Big Pharma executive and a four-star General have just been appointed by President Trump to lead a “Manhattan project-style effort to develop a vaccine for the novel coronavirus.” The effort, called Operation Warp Speed, has set a goal to create 300 million doses of a non-existent vaccine by January.

Moncef Slaoui, who used to run research and development for the world’s largest vaccine company, GlaxoSmithKline (GSK), oversaw the development of an Ebola vaccine in tandem with the American National Institutes of Health (NIH) and a biotech firm the company had acquired two years earlier, that was distributed in the West African nation of Liberia in 2015. Slaoui joined the board of directors of the Human Vaccines Project in 2018; a public-private partnership that intends to “accelerate the development of vaccines and immunotherapies against major global diseases” and counts with the participation of the biggest pharmaceutical companies in the world, including Sanofi Pasteur, Johnson & Johnson, Pfizer and, of course, GSK.

Read More: Trump Unveils Plan That Would See Big Pharma Reap Massive Profits from COVID-19 Vaccine

 

Renegade

From our advertisers